Cite
HARVARD Citation
Reverté, L. et al. (2022). Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes. Clinical and translational medicine. 12 (1), p. n/a. [Online].